Tackle Cancer Foundation
More Good News for Myeloma Patients Could Change Patterns of Treatment
Published in Drug Law Weekly, January 5th, 2010
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Continuous treatment is made possible by new types of cancer treatments that are more tolerable than...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2010-01-05)
More Articles from Drug Law Weekly
- Amgen
Amgen Resolves EPO Patent Dispute With Roche - Arrowhead Research Corporation
Arrowhead Announces $3.2 Million Private Placement - AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals Files Registration Statement for Initial Public Offering - Body Weight
Research: Dosage of Morphine for ill Newborns Still too Imprecise - Cannabis Science Inc.
Cannabis Science Begins National Television Educational Series Today With Traders Nation Airing National Tomorrow On CNN, ABC, Fox, CBS Marketwatch, and CNBC, Focusing On Educating Viewers On the GroundDA - Cardiome Pharma Corp.
Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
